AGRX - Agile Therapeutics Inc Stock Price, Fair Value and News

1.44USD0.00 (0.00%)Market Closed

Market Summary

USD1.440.00

Market Closed

0.00%

AGRX Stock Price

View Fullscreen

AGRX RSI Chart

AGRX Valuation

Market Cap

9.9M

Price/Earnings (Trailing)

-1.27

Price/Sales (Trailing)

0.46

EV/EBITDA

-1.12

Price/Free Cashflow

-0.94

AGRX Price/Sales (Trailing)

AGRX Profitability

Operating Margin

59.74%

EBT Margin

-36.25%

Return on Equity

-124.48%

Return on Assets

-61.8%

Free Cashflow Yield

-105.93%

AGRX Fundamentals

AGRX Revenue

Revenue (TTM)

21.5M

Rev. Growth (Yr)

49.91%

Rev. Growth (Qtr)

58.14%

AGRX Earnings

Earnings (TTM)

-7.8M

Earnings Growth (Yr)

123.82%

Earnings Growth (Qtr)

128.73%

Breaking Down AGRX Revenue

Last 7 days

0.7%

Last 90 days

260%

Trailing 12 Months

-45.0%

How does AGRX drawdown profile look like?

AGRX Financial Health

Current Ratio

0.56

Debt/Equity

2.63

Debt/Cashflow

-0.64

AGRX Investor Care

Shares Dilution (1Y)

593.27%

Diluted EPS (TTM)

-2.03

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	21.5M	0	0	0
2023	12.9M	16.3M	20.0M	19.6M
2022	5.7M	6.7M	8.4M	10.9M
2021	1.6M	2.5M	3.3M	4.1M
2020	0	0	0	749.0K

Get all data in R, Python etc through our Historical Stock Data APIs

About Agile Therapeutics Inc

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. The company was incorporated in 1997 and is headquartered in Princeton, New Jersey.

CEO	Mr. Alfred F. Altomari
WEBSITE	agiletherapeutics.com
INDUSTRY	Pharmaceuticals
EMPLOYEES	22

Agile Therapeutics Inc Frequently Asked Questions

What is the ticker symbol for Agile Therapeutics Inc? What does AGRX stand for in stocks?

AGRX is the stock ticker symbol of Agile Therapeutics Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Agile Therapeutics Inc (AGRX)?

As of Fri Jul 26 2024, market cap of Agile Therapeutics Inc is 9.87 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AGRX stock?

You can check AGRX's fair value in chart for subscribers.

Is Agile Therapeutics Inc a good stock to buy?

The fair value guage provides a quick view whether AGRX is over valued or under valued. Whether Agile Therapeutics Inc is cheap or expensive depends on the assumptions which impact Agile Therapeutics Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AGRX.

What is Agile Therapeutics Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, AGRX's PE ratio (Price to Earnings) is -1.27 and Price to Sales (PS) ratio is 0.46. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AGRX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Agile Therapeutics Inc's stock?

In the past 10 years, Agile Therapeutics Inc has provided -0.595 (multiply by 100 for percentage) rate of return.